H-D-Glu(Bzl)-OBzl*Tos

H-D-Glu(Bzl)-OBzl*Tos is a protected glutamic acid derivative featuring an N-terminal hydrogen (H-) and a side-chain carboxyl group masked as an OBzl benzyl ester, alongside a main-chain carboxyl group also esterified as OBzl, with the side-chain alpha-amino functionality bearing a benzyl (Bzl) substituent. The molecule therefore contains multiple benzyl-protected oxygen sites and a benzylated amino substituent pattern that collectively modulate polarity, solubility, and chemoselectivity during peptide coupling and subsequent deprotection. The presence of the Tosylate counterion (Tos) indicates an ion-pairing or salt-forming strategy that can support handling of the amino acid ester form and can influence crystallization behavior in synthetic workflows. The stereochemical identity of glutamate (D-configuration) makes the compound a chiral amino acid building block suitable for stereocontrolled incorporation into peptides, peptidomimetics, and biochemical probes.

1. Protected Amino Acid Synthesis

H-D-Glu(Bzl)-OBzl*Tos serves as a protected amino acid ester platform for preparing glutamate-containing intermediates in protected amino acid synthesis. The protected carboxyl groups as OBzl esters and the benzylated side-chain functionality enable orthogonal deprotection planning, where hydrogenolysis can remove benzyl groups while preserving other protecting-group elements introduced later in a synthetic sequence. The N-terminal hydrogen state supports selective conversion to activated coupling forms (e.g., via standard peptide coupling activation strategies) while maintaining the ester-protected carboxyls to prevent undesired side reactions. Downstream, the compound can be converted into glutamate building blocks for peptide assembly and for generating stereochemically defined glutamyl derivatives used in synthetic methodology development.

2. Peptide Synthesis

H-D-Glu(Bzl)-OBzl*Tos is suitable for peptide synthesis workflows requiring D-glutamate incorporation with benzyl-protected oxygen functionalities. The side-chain and main-chain ester protections as OBzl groups help suppress intramolecular cyclization and minimize competing acylation at carboxylate sites during coupling steps, while the chiral D-center supports stereochemically defined peptide backbones. The benzylated amino/side-chain pattern can be leveraged to tune reactivity and chemoselectivity, allowing the synthetic chemist to control when glutamate carboxyl groups become available for further transformations. After assembly, hydrogenolysis and subsequent functional group adjustments can furnish D-glutamyl peptides, glutamate-rich fragments, or protected peptide intermediates for continued elaboration toward peptidomimetics and structure-activity relationship studies.

3. Peptidomimetics And SAR Studies

H-D-Glu(Bzl)-OBzl*Tos supports peptidomimetic construction and SAR-oriented library synthesis where stereodefined glutamate residues are required as functional scaffolds. The D-glutamate stereochemistry and the benzyl-protected carboxyl groups provide a controlled handle set for converting protected oxygen sites into free carboxylates, amides, or other derivatives that mimic acidic side-chain recognition motifs. The molecule's protected form can be incorporated into larger synthetic fragments without prematurely exposing carboxyl groups, enabling sequential functionalization and side-chain modification strategies that map onto binding-site hypotheses. Resulting D-glutamate-containing analogs can be used to generate structure-activity relationship panels and to support fragment-based molecular design campaigns that require consistent stereochemical presentation of acidic functionality.

4. Bioconjugation Chemistry

H-D-Glu(Bzl)-OBzl*Tos can be applied in bioconjugation chemistry as a stereochemically defined glutamate-derived intermediate for constructing conjugation-ready linkers and functional handles. The protected glutamate carboxyl groups can be deprotected under hydrogenolysis-compatible conditions to yield carboxylate functionality for subsequent activation to amide or ester linkages, enabling attachment to biomolecule surfaces or to carrier proteins. The benzyl-protected oxygen framework helps maintain stability during coupling steps that may involve aqueous buffers or nucleophilic reagents, depending on the protection strategy used in the conjugation sequence. Downstream conjugates can be designed for chemical biology experiments such as mapping binding interfaces, preparing labeled peptide conjugates, or generating immobilized glutamate-containing probes for analytical and screening workflows.

5. Pharmaceutical Intermediate Preparation

H-D-Glu(Bzl)-OBzl*Tos is relevant to pharmaceutical intermediate preparation where protected amino acid derivatives are used to build stereochemically defined fragments for drug-like molecules and peptide-based candidates. The compound's benzyl ester protections on glutamate oxygen sites support controlled downstream transformations, including conversion to activated acylating species or incorporation into larger synthetic sequences without uncontrolled hydrolysis of carboxyl groups. The D-configuration provides a stereochemical element that can be important for minimizing epimerization during process development and for enabling consistent stereochemical outcomes in route design. The tosylate-associated handling characteristics can be leveraged in manufacturing-oriented workflows to manage salt formation and isolation behavior while maintaining compatibility with standard amino acid derivative processing and fine chemical synthesis.

6. Process Chemistry Intermediate

H-D-Glu(Bzl)-OBzl*Tos can function as a process chemistry intermediate for producing protected D-glutamate building blocks used in industrial fine chemical synthesis. The benzyl ester protection pattern provides a practical protection/deprotection logic that aligns with hydrogenolysis steps commonly used in manufacturing to unmask carboxylates while avoiding harsh conditions that could compromise other functional groups. The presence of multiple protected oxygen sites supports predictable chemoselectivity during activation and coupling operations, which is beneficial for controlling impurity formation pathways in scale-up contexts. Resulting intermediates can be further processed into glutamate-containing peptides, peptidomimetics, or functionalized amino acid derivatives, linking amino acid derivatization chemistry to downstream production of specialty chemical products and biochemical research materials.

1. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

2. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

3. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis